Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 799 entries
Sorted by: Best Match Show Resources per page
Analysis of the microbial species, antimicrobial sensitivity and drug resistance in 2652 patients of nursing hospital.

Heliyon

Yang W, Ji X.
PMID: 32490228
Heliyon. 2020 May 18;6(5):e03965. doi: 10.1016/j.heliyon.2020.e03965. eCollection 2020 May.

OBJECTIVE: To understand the microbial species, antimicrobial sensitivity and drug resistance of patients in the nursing hospital, to bring clinical guiding significance to the use of antimicrobial in the nursing hospital.METHODS: A retrospective analysis of bacterial and drug sensitivity...

Cite
Yang W, Ji X. Analysis of the microbial species, antimicrobial sensitivity and drug resistance in 2652 patients of nursing hospital. Heliyon. 2020;6(5):e03965doi: 10.1016/j.heliyon.2020.e03965.
Yang, W., & Ji, X. (2020). Analysis of the microbial species, antimicrobial sensitivity and drug resistance in 2652 patients of nursing hospital. Heliyon, 6(5), e03965. https://doi.org/10.1016/j.heliyon.2020.e03965
Yang, Wu, and Ji, Xu. "Analysis of the microbial species, antimicrobial sensitivity and drug resistance in 2652 patients of nursing hospital." Heliyon vol. 6,5 (2020): e03965. doi: https://doi.org/10.1016/j.heliyon.2020.e03965
Yang W, Ji X. Analysis of the microbial species, antimicrobial sensitivity and drug resistance in 2652 patients of nursing hospital. Heliyon. 2020 May 18;6(5):e03965. doi: 10.1016/j.heliyon.2020.e03965. eCollection 2020 May. PMID: 32490228; PMCID: PMC7260137.
Copy Download .nbib Format: NLM
Indian Society of Critical Care Medicine Position Statement for Central Venous Catheterization and Management 2020.

Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine

Javeri Y, Jagathkar G, Dixit S, Chaudhary D, Zirpe KG, Mehta Y, Govil D, Mishra RC, Samavedam S, Pandit RA, Savio RD, Clerk AM, Srinivasan S, Juneja D, Ray S, Sahoo TK, Jakkinaboina S, Jampala N, Jain R.
PMID: 32205954
Indian J Crit Care Med. 2020 Jan;24:S6-S30. doi: 10.5005/jp-journals-10071-G23183.

BACKGROUND AND PURPOSE: Short-term central venous catheterization (CVC) is one of the commonly used invasive interventions in ICU and other patient-care areas. Practice and management of CVC is not standardized, varies widely, and need appropriate guidance. Purpose of this...

Cite
Javeri Y, Jagathkar G, Dixit S, et al. Indian Society of Critical Care Medicine Position Statement for Central Venous Catheterization and Management 2020. Indian J Crit Care Med. 2020;24:S6-S30doi: 10.5005/jp-journals-10071-G23183.
Javeri, Y., Jagathkar, G., Dixit, S., Chaudhary, D., Zirpe, K. G., Mehta, Y., Govil, D., Mishra, R. C., Samavedam, S., Pandit, R. A., Savio, R. D., Clerk, A. M., Srinivasan, S., Juneja, D., Ray, S., Sahoo, T. K., Jakkinaboina, S., Jampala, N., & Jain, R. (2020). Indian Society of Critical Care Medicine Position Statement for Central Venous Catheterization and Management 2020. Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine, 24S6-S30. https://doi.org/10.5005/jp-journals-10071-G23183
Javeri, Yash, et al. "Indian Society of Critical Care Medicine Position Statement for Central Venous Catheterization and Management 2020." Indian journal of critical care medicine : peer-reviewed, official publication of Indian Society of Critical Care Medicine vol. 24 (2020): S6-S30. doi: https://doi.org/10.5005/jp-journals-10071-G23183
Javeri Y, Jagathkar G, Dixit S, Chaudhary D, Zirpe KG, Mehta Y, Govil D, Mishra RC, Samavedam S, Pandit RA, Savio RD, Clerk AM, Srinivasan S, Juneja D, Ray S, Sahoo TK, Jakkinaboina S, Jampala N, Jain R. Indian Society of Critical Care Medicine Position Statement for Central Venous Catheterization and Management 2020. Indian J Crit Care Med. 2020 Jan;24:S6-S30. doi: 10.5005/jp-journals-10071-G23183. PMID: 32205954; PMCID: PMC7085816.
Copy Download .nbib Format: NLM
ISMP Adverse Drug Reactions: Pregabalin-Induced Stuttering Nitroglycerine-Induced Bradycardia Progressing to Asystole Minocycline-Induced DRESS Leading to Liver Transplantation and Type 1 Diabetes Increased Risk of Vertebral Fractures in Women Receiving Thiazide or Loop Diuretics Gambling Disorder and Impulse Control Disorder with Aripiprazole.

Hospital pharmacy

Mancano MA.
PMID: 28515502
Hosp Pharm. 2017 Apr;52(4):253-257. doi: 10.1310/hpj5204-253.

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported...

Cite
Mancano MA. ISMP Adverse Drug Reactions: Pregabalin-Induced Stuttering Nitroglycerine-Induced Bradycardia Progressing to Asystole Minocycline-Induced DRESS Leading to Liver Transplantation and Type 1 Diabetes Increased Risk of Vertebral Fractures in Women Receiving Thiazide or Loop Diuretics Gambling Disorder and Impulse Control Disorder with Aripiprazole. Hosp Pharm. 2017;52(4):253-257doi: 10.1310/hpj5204-253.
Mancano, M. A. (2017). ISMP Adverse Drug Reactions: Pregabalin-Induced Stuttering Nitroglycerine-Induced Bradycardia Progressing to Asystole Minocycline-Induced DRESS Leading to Liver Transplantation and Type 1 Diabetes Increased Risk of Vertebral Fractures in Women Receiving Thiazide or Loop Diuretics Gambling Disorder and Impulse Control Disorder with Aripiprazole. Hospital pharmacy, 52(4), 253-257. https://doi.org/10.1310/hpj5204-253
Mancano, Michael A. "ISMP Adverse Drug Reactions: Pregabalin-Induced Stuttering Nitroglycerine-Induced Bradycardia Progressing to Asystole Minocycline-Induced DRESS Leading to Liver Transplantation and Type 1 Diabetes Increased Risk of Vertebral Fractures in Women Receiving Thiazide or Loop Diuretics Gambling Disorder and Impulse Control Disorder with Aripiprazole." Hospital pharmacy vol. 52,4 (2017): 253-257. doi: https://doi.org/10.1310/hpj5204-253
Mancano MA. ISMP Adverse Drug Reactions: Pregabalin-Induced Stuttering Nitroglycerine-Induced Bradycardia Progressing to Asystole Minocycline-Induced DRESS Leading to Liver Transplantation and Type 1 Diabetes Increased Risk of Vertebral Fractures in Women Receiving Thiazide or Loop Diuretics Gambling Disorder and Impulse Control Disorder with Aripiprazole. Hosp Pharm. 2017 Apr;52(4):253-257. doi: 10.1310/hpj5204-253. PMID: 28515502; PMCID: PMC5424827.
Copy Download .nbib Format: NLM
Adjunctive antibiotics with nonsurgical periodontal therapy improve the clinical outcome of chronic periodontitis in current smokers.

The journal of evidence-based dental practice

Albandar JM.
PMID: 23253833
J Evid Based Dent Pract. 2012 Sep;12(3):63-6. doi: 10.1016/S1532-3382(12)70015-5.

SELECTION CRITERIA: A systematic review was performed to identify randomized, controlled, clinical trials designed to study the efficacy of adjunctive antimicrobial therapy with periodontal treatment of chronic periodontitis in smokers. A search was carried out using the databases PubMed...

Cite
Albandar JM. Adjunctive antibiotics with nonsurgical periodontal therapy improve the clinical outcome of chronic periodontitis in current smokers. J Evid Based Dent Pract. 2012;12(3):63-6doi: 10.1016/S1532-3382(12)70015-5.
Albandar, J. M. (2012). Adjunctive antibiotics with nonsurgical periodontal therapy improve the clinical outcome of chronic periodontitis in current smokers. The journal of evidence-based dental practice, 12(3), 63-6. https://doi.org/10.1016/S1532-3382(12)70015-5
Albandar, Jasim M. "Adjunctive antibiotics with nonsurgical periodontal therapy improve the clinical outcome of chronic periodontitis in current smokers." The journal of evidence-based dental practice vol. 12,3 (2012): 63-6. doi: https://doi.org/10.1016/S1532-3382(12)70015-5
Albandar JM. Adjunctive antibiotics with nonsurgical periodontal therapy improve the clinical outcome of chronic periodontitis in current smokers. J Evid Based Dent Pract. 2012 Sep;12(3):63-6. doi: 10.1016/S1532-3382(12)70015-5. PMID: 23253833.
Copy Download .nbib Format: NLM
Herpes Zoster Caused by Zoster Vaccine in an Immunocompetent Patient; Restless Leg Syndrome Due to the Combination of Venlafaxine and Quetiapine; SSRIs and the Risk of Upper Gastrointestinal Bleeding; Minocycline-Induced Cutaneous Polyarteritis Nodosa.

Hospital pharmacy

Mancano MA.
PMID: 25477576
Hosp Pharm. 2014 Jul;49(7):599-602. doi: 10.1310/hpj4907-599.

The purpose of this feature is to heighten awareness of specific adverse drug reactions (ADRs), discuss methods of prevention, and promote reporting of ADRs to the US Food and Drug Administration's (FDA's) MedWatch program (800-FDA-1088). If you have reported...

Cite
Mancano MA. Herpes Zoster Caused by Zoster Vaccine in an Immunocompetent Patient; Restless Leg Syndrome Due to the Combination of Venlafaxine and Quetiapine; SSRIs and the Risk of Upper Gastrointestinal Bleeding; Minocycline-Induced Cutaneous Polyarteritis Nodosa. Hosp Pharm. 2014;49(7):599-602doi: 10.1310/hpj4907-599.
Mancano, M. A. (2014). Herpes Zoster Caused by Zoster Vaccine in an Immunocompetent Patient; Restless Leg Syndrome Due to the Combination of Venlafaxine and Quetiapine; SSRIs and the Risk of Upper Gastrointestinal Bleeding; Minocycline-Induced Cutaneous Polyarteritis Nodosa. Hospital pharmacy, 49(7), 599-602. https://doi.org/10.1310/hpj4907-599
Mancano, Michael A. "Herpes Zoster Caused by Zoster Vaccine in an Immunocompetent Patient; Restless Leg Syndrome Due to the Combination of Venlafaxine and Quetiapine; SSRIs and the Risk of Upper Gastrointestinal Bleeding; Minocycline-Induced Cutaneous Polyarteritis Nodosa." Hospital pharmacy vol. 49,7 (2014): 599-602. doi: https://doi.org/10.1310/hpj4907-599
Mancano MA. Herpes Zoster Caused by Zoster Vaccine in an Immunocompetent Patient; Restless Leg Syndrome Due to the Combination of Venlafaxine and Quetiapine; SSRIs and the Risk of Upper Gastrointestinal Bleeding; Minocycline-Induced Cutaneous Polyarteritis Nodosa. Hosp Pharm. 2014 Jul;49(7):599-602. doi: 10.1310/hpj4907-599. PMID: 25477576; PMCID: PMC4252227.
Copy Download .nbib Format: NLM
ISMP Adverse Drug Reactions: Minocycline-Induced Drug Fever Without Skin Rash Lupus Erythematosus-Like Eruption Induced by Hydroxyurea Cardiotoxicity and Fever Induced by Clozapine Denosumab-Induced Hepatotoxicity Severe Cardiotoxicity Induced by Bevacizumab.

Hospital pharmacy

Mancano MA.
PMID: 29581602
Hosp Pharm. 2018 Apr;53(2):93-95. doi: 10.1177/0018578718756666. Epub 2018 Feb 07.

No abstract available.

Cite
Mancano MA. ISMP Adverse Drug Reactions: Minocycline-Induced Drug Fever Without Skin Rash Lupus Erythematosus-Like Eruption Induced by Hydroxyurea Cardiotoxicity and Fever Induced by Clozapine Denosumab-Induced Hepatotoxicity Severe Cardiotoxicity Induced by Bevacizumab. Hosp Pharm. 2018;53(2):93-95doi: 10.1177/0018578718756666.
Mancano, M. A. (2018). ISMP Adverse Drug Reactions: Minocycline-Induced Drug Fever Without Skin Rash Lupus Erythematosus-Like Eruption Induced by Hydroxyurea Cardiotoxicity and Fever Induced by Clozapine Denosumab-Induced Hepatotoxicity Severe Cardiotoxicity Induced by Bevacizumab. Hospital pharmacy, 53(2), 93-95. https://doi.org/10.1177/0018578718756666
Mancano, Michael A. "ISMP Adverse Drug Reactions: Minocycline-Induced Drug Fever Without Skin Rash Lupus Erythematosus-Like Eruption Induced by Hydroxyurea Cardiotoxicity and Fever Induced by Clozapine Denosumab-Induced Hepatotoxicity Severe Cardiotoxicity Induced by Bevacizumab." Hospital pharmacy vol. 53,2 (2018): 93-95. doi: https://doi.org/10.1177/0018578718756666
Mancano MA. ISMP Adverse Drug Reactions: Minocycline-Induced Drug Fever Without Skin Rash Lupus Erythematosus-Like Eruption Induced by Hydroxyurea Cardiotoxicity and Fever Induced by Clozapine Denosumab-Induced Hepatotoxicity Severe Cardiotoxicity Induced by Bevacizumab. Hosp Pharm. 2018 Apr;53(2):93-95. doi: 10.1177/0018578718756666. Epub 2018 Feb 07. PMID: 29581602; PMCID: PMC5863889.
Copy Download .nbib Format: NLM
Insight into the mechanisms of type III minocycline-induced pigmentation removal: A case of repeated immediate pigment clearing with the Q-switched 755-nm alexandrite laser over a 13-year period.

JAAD case reports

Loh TY, Goldberg MS, Falsey RR, Barton JK, Sagerman P, Goldberg GN.
PMID: 31649974
JAAD Case Rep. 2019 Sep 24;5(10):865-867. doi: 10.1016/j.jdcr.2019.07.030. eCollection 2019 Oct.

No abstract available.

Cite
Loh TY, Goldberg MS, Falsey RR, et al. Insight into the mechanisms of type III minocycline-induced pigmentation removal: A case of repeated immediate pigment clearing with the Q-switched 755-nm alexandrite laser over a 13-year period. JAAD Case Rep. 2019;5(10):865-867doi: 10.1016/j.jdcr.2019.07.030.
Loh, T. Y., Goldberg, M. S., Falsey, R. R., Barton, J. K., Sagerman, P., & Goldberg, G. N. (2019). Insight into the mechanisms of type III minocycline-induced pigmentation removal: A case of repeated immediate pigment clearing with the Q-switched 755-nm alexandrite laser over a 13-year period. JAAD case reports, 5(10), 865-867. https://doi.org/10.1016/j.jdcr.2019.07.030
Loh, Tiffany Y, et al. "Insight into the mechanisms of type III minocycline-induced pigmentation removal: A case of repeated immediate pigment clearing with the Q-switched 755-nm alexandrite laser over a 13-year period." JAAD case reports vol. 5,10 (2019): 865-867. doi: https://doi.org/10.1016/j.jdcr.2019.07.030
Loh TY, Goldberg MS, Falsey RR, Barton JK, Sagerman P, Goldberg GN. Insight into the mechanisms of type III minocycline-induced pigmentation removal: A case of repeated immediate pigment clearing with the Q-switched 755-nm alexandrite laser over a 13-year period. JAAD Case Rep. 2019 Sep 24;5(10):865-867. doi: 10.1016/j.jdcr.2019.07.030. eCollection 2019 Oct. PMID: 31649974; PMCID: PMC6804476.
Copy Download .nbib Format: NLM
In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes.

The Journal of clinical and aesthetic dermatology

Leyden JJ, Preston N, Osborn C, Gottschalk RW.
PMID: 21607190
J Clin Aesthet Dermatol. 2011 May;4(5):22-6.

BACKGROUND: A gel combination treatment containing a retinoid (adapalene 0.1%) and an antimicrobial (benzoyl peroxide 2.5%) has been shown to be an effective treatment for acne vulgaris, addressing three of the four pathogenic factors (hyperkeratinization, Propionibacterium acnes proliferation, inflammation)...

Cite
Leyden JJ, Preston N, Osborn C, et al. In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes. J Clin Aesthet Dermatol. 2011;4(5):22-6
Leyden, J. J., Preston, N., Osborn, C., & Gottschalk, R. W. (2011). In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes. The Journal of clinical and aesthetic dermatology, 4(5), 22-6.
Leyden, James J, et al. "In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes." The Journal of clinical and aesthetic dermatology vol. 4,5 (2011): 22-6.
Leyden JJ, Preston N, Osborn C, Gottschalk RW. In-vivo Effectiveness of Adapalene 0.1%/Benzoyl Peroxide 2.5% Gel on Antibiotic-sensitive and Resistant Propionibacterium acnes. J Clin Aesthet Dermatol. 2011 May;4(5):22-6. PMID: 21607190; PMCID: PMC3100113.
Copy Download .nbib Format: NLM
Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat.

Current infectious disease reports

Butler DA, Biagi M, Tan X, Qasmieh S, Bulman ZP, Wenzler E.
PMID: 31734740
Curr Infect Dis Rep. 2019 Nov 16;21(12):46. doi: 10.1007/s11908-019-0706-5.

PURPOSE OF REVIEW: Acinetobacter baumannii (AB) is an infamous nosocomial pathogen with a seemingly limitless capacity for antimicrobial resistance, leading to few treatment options and poor clinical outcomes. The debatably low pathogenicity and virulence of AB are juxtaposed by...

Cite
Butler DA, Biagi M, Tan X, et al. Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat. Curr Infect Dis Rep. 2019;21(12):46doi: 10.1007/s11908-019-0706-5.
Butler, D. A., Biagi, M., Tan, X., Qasmieh, S., Bulman, Z. P., & Wenzler, E. (2019). Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat. Current infectious disease reports, 21(12), 46. https://doi.org/10.1007/s11908-019-0706-5
Butler, David A, et al. "Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat." Current infectious disease reports vol. 21,12 (2019): 46. doi: https://doi.org/10.1007/s11908-019-0706-5
Butler DA, Biagi M, Tan X, Qasmieh S, Bulman ZP, Wenzler E. Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat. Curr Infect Dis Rep. 2019 Nov 16;21(12):46. doi: 10.1007/s11908-019-0706-5. PMID: 31734740.
Copy Download .nbib Format: NLM
Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review.

IBRO neuroscience reports

Aly E, Masocha W.
PMID: 34179865
IBRO Neurosci Rep. 2021 Jan 25;10:109-118. doi: 10.1016/j.ibneur.2021.01.004. eCollection 2021 Jun.

Human immunodeficiency virus (HIV) infection and antiretroviral therapy can independently induce HIV-associated neuropathic pain (HIV-NP). There is a dearth of drugs or therapeutic modalities that can alleviate HIV-NP. Smoked cannabis has been reported to improve pain measures in patients...

Cite
Aly E, Masocha W. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review. IBRO Neurosci Rep. 2021;10:109-118doi: 10.1016/j.ibneur.2021.01.004.
Aly, E., & Masocha, W. (2021). Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review. IBRO neuroscience reports, 10109-118. https://doi.org/10.1016/j.ibneur.2021.01.004
Aly, Esraa, and Masocha, Willias. "Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review." IBRO neuroscience reports vol. 10 (2021): 109-118. doi: https://doi.org/10.1016/j.ibneur.2021.01.004
Aly E, Masocha W. Targeting the endocannabinoid system for management of HIV-associated neuropathic pain: A systematic review. IBRO Neurosci Rep. 2021 Jan 25;10:109-118. doi: 10.1016/j.ibneur.2021.01.004. eCollection 2021 Jun. PMID: 34179865; PMCID: PMC8211923.
Copy Download .nbib Format: NLM
Microglial Activation of GLP-1R Signaling in Neuropathic Pain Promotes Gene Expression Adaption Involved in Inflammatory Responses.

Neural plasticity

Ma L, Ju P, Wang W, Wei J, Wang W, Zhao M, Ahmad KA, Wang Y, Chen J.
PMID: 34512747
Neural Plast. 2021 Aug 31;2021:9923537. doi: 10.1155/2021/9923537. eCollection 2021.

BACKGROUND: Neuropathic pain is a common chronic pain, which is related to hypersensitivity to stimulus and greatly affects the quality of life of patients. Maladaptive gene changes and molecular signaling underlie the sensitization of nociceptive pathways. We previously found...

Cite
Ma L, Ju P, Wang W, et al. Microglial Activation of GLP-1R Signaling in Neuropathic Pain Promotes Gene Expression Adaption Involved in Inflammatory Responses. Neural Plast. 2021;2021:9923537doi: 10.1155/2021/9923537.
Ma, L., Ju, P., Wang, W., Wei, J., Wang, W., Zhao, M., Ahmad, K. A., Wang, Y., & Chen, J. (2021). Microglial Activation of GLP-1R Signaling in Neuropathic Pain Promotes Gene Expression Adaption Involved in Inflammatory Responses. Neural plasticity, 20219923537. https://doi.org/10.1155/2021/9923537
Ma, Le, et al. "Microglial Activation of GLP-1R Signaling in Neuropathic Pain Promotes Gene Expression Adaption Involved in Inflammatory Responses." Neural plasticity vol. 2021 (2021): 9923537. doi: https://doi.org/10.1155/2021/9923537
Ma L, Ju P, Wang W, Wei J, Wang W, Zhao M, Ahmad KA, Wang Y, Chen J. Microglial Activation of GLP-1R Signaling in Neuropathic Pain Promotes Gene Expression Adaption Involved in Inflammatory Responses. Neural Plast. 2021 Aug 31;2021:9923537. doi: 10.1155/2021/9923537. eCollection 2021. PMID: 34512747; PMCID: PMC8426070.
Copy Download .nbib Format: NLM
Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran.

Iranian journal of microbiology

Mohajeri P, Farahani A, Feizabadi MM, Ketabi H, Abiri R, Najafi F.
PMID: 24475323
Iran J Microbiol. 2013 Sep;5(3):195-202.

BACKGROUND AND OBJECTIVE: Acinetobacter baumannii is an aerobic non-motile Gram-negative bacterial pathogen that is resistant to most antibiotics. Carbapenems are the most common antibiotics for the treatment of infections caused by this pathogen. Mechanisms of antibiotic-resistance in A. baumannii...

Cite
Mohajeri P, Farahani A, Feizabadi MM, et al. Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran. Iran J Microbiol. 2013;5(3):195-202
Mohajeri, P., Farahani, A., Feizabadi, M. M., Ketabi, H., Abiri, R., & Najafi, F. (2013). Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran. Iranian journal of microbiology, 5(3), 195-202.
Mohajeri, Parviz, et al. "Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran." Iranian journal of microbiology vol. 5,3 (2013): 195-202.
Mohajeri P, Farahani A, Feizabadi MM, Ketabi H, Abiri R, Najafi F. Antimicrobial susceptibility profiling and genomic diversity of Acinetobacter baumannii isolates: A study in western Iran. Iran J Microbiol. 2013 Sep;5(3):195-202. PMID: 24475323; PMCID: PMC3895554.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 799 entries